{"id":30526,"date":"2025-04-17T13:24:52","date_gmt":"2025-04-17T12:24:52","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/info-communication\/news\/white-book-antibiotic-therapy-everyones-business\/"},"modified":"2025-08-07T16:46:38","modified_gmt":"2025-08-07T15:46:38","slug":"white-book-antibiotic-therapy-everyones-business","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/","title":{"rendered":"White book : &#8220;Antibiotic therapy: everyone&#8217;s business&#8221;"},"content":{"rendered":"\n<p>The white paper \u2018Antibiotic therapy: everyone&#8217;s business\u2019 is the result of fruitful discussions between professionals in the sector during a conference-debate and a temporary think tank in June and September 2024.<\/p>\n\n<p>Produced at the request of Pfizer in partnership with the Pasteur Institute, Biom\u00e9rieux, BEAM Alliance, the National Industry Council, and with the support of the Scientific Council&#8217;s Antibiotic Resistance Working Group, this book addresses three fundamental areas:<\/p>\n\n<ul>\n<li>Promote prevention practices, infection control and the proper use of antibiotics.<\/li>\n\n\n\n<li>Promoting R&amp;D with the aim of fostering innovation and preserving the effectiveness of existing antibiotics<\/li>\n\n\n\n<li>Rethinking antibiotic treatment funding models<\/li>\n<\/ul>\n\n<div class=\"wp-block-columns is-layout-flex wp-container-core-columns-is-layout-1 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:33.33%\">\n<figure data-wp-context=\"{&quot;uploadedSrc&quot;:&quot;https:\\\/\\\/ppr-antibioresistance.inserm.fr\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/Livre-blanc-Lantibiotherapie-laffaire-de-tous.png&quot;,&quot;figureClassNames&quot;:&quot;wp-block-image size-large&quot;,&quot;figureStyles&quot;:null,&quot;imgClassNames&quot;:&quot;wp-image-30346&quot;,&quot;imgStyles&quot;:null,&quot;targetWidth&quot;:795,&quot;targetHeight&quot;:1057,&quot;scaleAttr&quot;:false,&quot;ariaLabel&quot;:&quot;Enlarge image&quot;,&quot;alt&quot;:&quot;&quot;}\" data-wp-interactive=\"core\/image\" class=\"wp-block-image size-large wp-lightbox-container\"><img fetchpriority=\"high\" decoding=\"async\" width=\"770\" height=\"1024\" data-wp-init=\"callbacks.setButtonStyles\" data-wp-on--click=\"actions.showLightbox\" data-wp-on--load=\"callbacks.setButtonStyles\" data-wp-on-window--resize=\"callbacks.setButtonStyles\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/04\/Livre-blanc-Lantibiotherapie-laffaire-de-tous-770x1024.png\" alt=\"\" class=\"wp-image-30346\" srcset=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/04\/Livre-blanc-Lantibiotherapie-laffaire-de-tous-770x1024.png 770w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/04\/Livre-blanc-Lantibiotherapie-laffaire-de-tous-226x300.png 226w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/04\/Livre-blanc-Lantibiotherapie-laffaire-de-tous-768x1021.png 768w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/04\/Livre-blanc-Lantibiotherapie-laffaire-de-tous.png 795w\" sizes=\"(max-width: 770px) 100vw, 770px\" \/><button\n\t\t\tclass=\"lightbox-trigger\"\n\t\t\ttype=\"button\"\n\t\t\taria-haspopup=\"dialog\"\n\t\t\taria-label=\"Enlarge image\"\n\t\t\tdata-wp-init=\"callbacks.initTriggerButton\"\n\t\t\tdata-wp-on--click=\"actions.showLightbox\"\n\t\t\tdata-wp-style--right=\"context.imageButtonRight\"\n\t\t\tdata-wp-style--top=\"context.imageButtonTop\"\n\t\t>\n\t\t\t<svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"12\" height=\"12\" fill=\"none\" viewBox=\"0 0 12 12\">\n\t\t\t\t<path fill=\"#fff\" d=\"M2 0a2 2 0 0 0-2 2v2h1.5V2a.5.5 0 0 1 .5-.5h2V0H2Zm2 10.5H2a.5.5 0 0 1-.5-.5V8H0v2a2 2 0 0 0 2 2h2v-1.5ZM8 12v-1.5h2a.5.5 0 0 0 .5-.5V8H12v2a2 2 0 0 1-2 2H8Zm2-12a2 2 0 0 1 2 2v2h-1.5V2a.5.5 0 0 0-.5-.5H8V0h2Z\" \/>\n\t\t\t<\/svg>\n\t\t<\/button><\/figure>\n<\/div>\n\n\n\n<div class=\"wp-block-column is-vertically-aligned-bottom is-layout-flow wp-block-column-is-layout-flow\" style=\"flex-basis:66.66%\">\n<p><strong>White book : &#8220;Antibiotic therapy: everyone&#8217;s business&#8221;<\/strong><\/p>\n\n\n\n<p>\u2018In 2015, the report \u2019Tous ensemble, sauvons les antibiotiques\u2018 (Let&#8217;s work together to save antibiotics) highlighted the urgent need to make antibiotic therapy a public health priority in response to the overuse of antibiotics and antibiotic resistance. Ten years later, these challenges remain pressing.\u2019<\/p>\n\n\n\n<div class=\"wp-block-buttons has-custom-font-size has-small-font-size is-content-justification-left is-layout-flex wp-container-core-buttons-is-layout-1 wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button has-custom-font-size is-style-outline has-small-font-size\"><a class=\"wp-block-button__link has-luminous-vivid-orange-color has-text-color has-link-color wp-element-button\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/04\/Lantibiotherapie-laffaire-de-tous.pdf\"><strong>Read the white paper<\/strong><\/a><\/div>\n<\/div>\n\n\n\n<div style=\"height:20px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The white paper \u2018Antibiotic therapy: everyone&#8217;s business\u2019 is the result of fruitful discussions between professionals in the sector during a conference-debate and a temporary think tank in June and September 2024. Produced at the request of Pfizer in partnership with the Pasteur Institute, Biom\u00e9rieux, BEAM Alliance, the National Industry Council, and with the support of [&hellip;]<\/p>\n","protected":false},"author":275,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[58,56,62],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>White book : &quot;Antibiotic therapy: everyone&#039;s business&quot; - French\u00a0National ANTIBIOTIC RESISTANCE Portal<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"White book : &quot;Antibiotic therapy: everyone&#039;s business&quot; - French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/\" \/>\n<meta property=\"og:site_name\" content=\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-17T12:24:52+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-07T15:46:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/04\/Livre-blanc-Lantibiotherapie-laffaire-de-tous-770x1024.png\" \/>\n<meta name=\"author\" content=\"supportmlcom\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"supportmlcom\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/\"},\"author\":{\"name\":\"supportmlcom\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5\"},\"headline\":\"White book : &#8220;Antibiotic therapy: everyone&#8217;s business&#8221;\",\"datePublished\":\"2025-04-17T12:24:52+00:00\",\"dateModified\":\"2025-08-07T15:46:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/\"},\"wordCount\":160,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/04\/Livre-blanc-Lantibiotherapie-laffaire-de-tous-770x1024.png\",\"articleSection\":[\"News\",\"Practical info &amp; communications\",\"Reviews, reports and recommendations\"],\"inLanguage\":\"en-GB\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/\",\"name\":\"White book : \\\"Antibiotic therapy: everyone's business\\\" - French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/04\/Livre-blanc-Lantibiotherapie-laffaire-de-tous-770x1024.png\",\"datePublished\":\"2025-04-17T12:24:52+00:00\",\"dateModified\":\"2025-08-07T15:46:38+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/04\/Livre-blanc-Lantibiotherapie-laffaire-de-tous-770x1024.png\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/04\/Livre-blanc-Lantibiotherapie-laffaire-de-tous-770x1024.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Practical info &amp; communications\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"White book : \u201cAntibiotic therapy: everyone\u2019s business\u201d\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"name\":\"French\u00a0National ANTIBIOTIC RESISTANCE Portal\",\"description\":\"INSERM - From science to health\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5\",\"name\":\"supportmlcom\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"White book : \"Antibiotic therapy: everyone's business\" - French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/","og_locale":"en_GB","og_type":"article","og_title":"White book : \"Antibiotic therapy: everyone's business\" - French\u00a0National ANTIBIOTIC RESISTANCE Portal","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/","og_site_name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","article_published_time":"2025-04-17T12:24:52+00:00","article_modified_time":"2025-08-07T15:46:38+00:00","og_image":[{"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/04\/Livre-blanc-Lantibiotherapie-laffaire-de-tous-770x1024.png"}],"author":"supportmlcom","twitter_card":"summary_large_image","twitter_misc":{"Written by":"supportmlcom","Estimated reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/"},"author":{"name":"supportmlcom","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5"},"headline":"White book : &#8220;Antibiotic therapy: everyone&#8217;s business&#8221;","datePublished":"2025-04-17T12:24:52+00:00","dateModified":"2025-08-07T15:46:38+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/"},"wordCount":160,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/04\/Livre-blanc-Lantibiotherapie-laffaire-de-tous-770x1024.png","articleSection":["News","Practical info &amp; communications","Reviews, reports and recommendations"],"inLanguage":"en-GB"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/","name":"White book : \"Antibiotic therapy: everyone's business\" - French\u00a0National ANTIBIOTIC RESISTANCE Portal","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/04\/Livre-blanc-Lantibiotherapie-laffaire-de-tous-770x1024.png","datePublished":"2025-04-17T12:24:52+00:00","dateModified":"2025-08-07T15:46:38+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/04\/Livre-blanc-Lantibiotherapie-laffaire-de-tous-770x1024.png","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/04\/Livre-blanc-Lantibiotherapie-laffaire-de-tous-770x1024.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/white-book-antibiotic-therapy-everyones-business\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Practical info &amp; communications","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/info-communication\/news\/"},{"@type":"ListItem","position":4,"name":"White book : \u201cAntibiotic therapy: everyone\u2019s business\u201d"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","name":"French\u00a0National ANTIBIOTIC RESISTANCE Portal","description":"INSERM - From science to health","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/#\/schema\/person\/126addd59310b0af2dd75ae8223445a5","name":"supportmlcom"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-04-30 19:00:08","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/30526"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/users\/275"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/comments?post=30526"}],"version-history":[{"count":1,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/30526\/revisions"}],"predecessor-version":[{"id":30527,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/posts\/30526\/revisions\/30527"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/media?parent=30526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/categories?post=30526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/en\/wp-json\/wp\/v2\/tags?post=30526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}